Product image of Mestinon (Pyridostigmine Bromide) supplied by GNH India

Mestinon

Active Ingredient:
Pyridostigmine Bromide
Origin:
EU

Mestinon (Pyridostigmine Bromide)

Pyridostigmine bromide, the active ingredient in Mestinon, is an acetylcholinesterase inhibitor presented as an oral tablet for oral use. It is employed to improve muscle strength in myasthenia gravis and to reverse the effects of non‑depolarizing neuromuscular blocking agents in surgical settings.
GNH India supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mestinon belongs to the anticholinesterase drug class and is used where increased acetylcholine at the neuromuscular junction is required.

  • Myasthenia gravis: enhances skeletal‑muscle strength and reduces fatigue.
  • Reversal of neuromuscular blockade: restores normal neuromuscular transmission after surgery.
  • Ocular myasthenia: improves eye‑muscle function and reduces ptosis.

How It Works

  • Pyridostigmine bromide reversibly inhibits acetylcholinesterase, the enzyme responsible for breaking down acetylcholine in the synaptic cleft. By slowing acetylcholine degradation, it raises the concentration of this neurotransmitter at nicotinic receptors on skeletal muscle, thereby enhancing neuromuscular transmission and improving muscle contraction.

Side Effects

Mestinon may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: increased bowel movements.
  • Abdominal cramps: intermittent stomach pain.
  • Increased salivation: excess oral secretions.
  • Muscle cramps: involuntary muscle tightening.
  • Sweating: excessive perspiration.

Serious or Rare Side Effects

  • Bradycardia: unusually slow heart rate.
  • Bronchospasm: narrowing of airway passages.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Cholinergic crisis: muscle weakness and respiratory difficulty.
  • Seizures: convulsive episodes in rare cases.

Precautions & Warnings

Before prescribing Mestinon, clinicians should consider several safety factors.

  • Dose adjustment in renal impairment: reduce dose as renal function declines.
  • Monitor for signs of cholinergic excess: watch for muscle twitching, sweating, or diarrhea.
  • Caution in patients with asthma or COPD: may exacerbate bronchospasm.
  • Avoid concomitant use with anticholinergic drugs: may diminish therapeutic effect.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk.
  • Store at room temperature: keep in the original container, protect from moisture.

Avoid Interactions

Mestinon can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Neostigmine: additive cholinergic effects may cause toxicity.
  • Beta‑blockers: may mask tachycardia that signals excess cholinergic activity.
  • Magnesium sulfate: potentiates neuromuscular blockade, increasing risk of respiratory depression.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents (e.g., atropine): reduce Mestinon’s effectiveness.
  • Inhaled anesthetics (e.g., succinylcholine): may prolong neuromuscular blockade.
  • Diuretics: can affect electrolyte balance, influencing drug response.

Frequently Asked Questions

Mestinon (pyridostigmine bromide) is prescribed for patients with myasthenia gravis to improve muscle strength, and it is also used to reverse the effects of non‑depolarizing neuromuscular blocking agents after surgery. In some cases, it helps manage ocular myasthenia, reducing eye‑muscle weakness.

Pyridostigmine bromide reversibly blocks acetylcholinesterase, the enzyme that breaks down acetylcholine at the neuromuscular junction. By inhibiting this enzyme, the drug raises acetylcholine levels, enhancing stimulation of nicotinic receptors on skeletal muscle and thereby improving muscle contraction.

The appropriate dose of Mestinon is individualized by a qualified prescriber based on the patient’s condition, severity, renal function, and response to therapy. Dosage adjustments are made to achieve optimal clinical benefit while minimizing side effects.

Safety data for pyridostigmine bromide in pregnancy and lactation are limited. It should only be used when the potential therapeutic benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To request Mestinon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mestinon (pyridostigmine) is a reversible, peripherally acting acetylcholinesterase inhibitor, similar to neostigmine but with a longer duration of action and less central nervous system penetration. It is often preferred for chronic management of myasthenia gravis because of its favorable dosing schedule.

Mestinon tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keeping the product in a dry, cool place helps maintain its stability and potency.

Mestinon is taken orally, usually in tablet form, with or without food as directed by the prescriber. The exact administration schedule—such as frequency and timing—depends on the individual’s therapeutic needs and response.

The most serious risks include cholinergic crisis, which can cause severe muscle weakness and respiratory failure, as well as bradycardia, bronchospasm, and rare allergic reactions. Prompt medical attention is required if any of these symptoms appear.

Mestinon is contraindicated in patients with known hypersensitivity to pyridostigmine or any component of the formulation. Caution is also advised for individuals with severe asthma, chronic obstructive pulmonary disease, or significant renal impairment, where the drug may exacerbate existing conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pyridostigmine Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT